Clinical Studies
The creators of NeoStrata®, Drs. Van Scott and Yu, are internationally recognized as visionaries and leaders in the field of cosmetic dermatology. They are the creators and original patent-holders of the first glycolic peel and discovered the rejuvenating power of Alpha Hydroxy and Polyhydroxy Acids (AHA/PHAs), revolutionizing the treatment of aging skin. They have been recognized with the most prestigious accolades in the field:
  • the first Gold Medal given by the International Academy of Cosmetic Dermatology
  • the Master of Dermatology Award from the American Academy of Dermatology
  • the first Head of the Dermatology Branch of the National Institutes of Health

Gluconolactone Improves Signs of Photoaging Among Women With Sensitive Skin

A gluconolactone PHA-containing regimen including the Exuviance Purifying Cleansing Gel, Soothing Toning Lotion, Multi-Protective Day Fluid SPF15 (morning application) and Evening Restorative Complex (evening application) was assessed on 25 women with sensitive skin and moderate to advanced photoaging. All parameters of photoaging were significantly improved after six and twelve weeks of twice daily use, including firmness, sallowness, fine lines, wrinkles, roughness, hyperpigmentation and pore size (p<0.05). Silicone replicas revealed a reduction in the appearance of fine lines and wrinkles by over 30% in twelve weeks. Significant improvements were also observed in skin dryness and scaling (p<0.05). The products were well tolerated by the sensitive skin panelists and any preexisting irritation was improved during treatment, including erythema, tightness and tingling (p<0.05).

Alternate Exuviance products
Gentle Cleansing Cream, Multi-Protective Day Creme SPF 15, Ultra Restorative Creme. Alternate NeoStrata products: NeoStrata Facial Cleanser, Daytime Protection Cream SPF 15, Ultra Moisturizing Face Cream.

References
Bernstein EF, Green BA, Edison B, Wildnauer RH. Poly Hydroxy Acids (PHAs): Clinical Uses for the Next Generation of Hydroxy Acids. Skin & Aging Sep. 2001 Supplement.

Mean Relative % Improvement
(Compared to Baseline)